Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies

BACKGROUND: Patients with restrictive or hypertrophic cardiomyopathy (RCM/HCM) and congenital heart disease (CHD) do not derive clinical benefit from inotropes and mechanical circulatory support. Concerns were expressed that the new heart allocation system implemented in October 2018 would disadvant...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Chouairi, Fouad, Mullan, Clancy W., Sen, Sounok, Mori, Makoto, Fuery, Michael, Elder, Robert W., Lesse, Joshua, Norton, Kelsey, Clark, Katherine A., Miller, P. Elliott, Mulligan, David, Formica, Richard, Rogers, Joseph G., Jacoby, Daniel, Maulion, Christopher, Anwer, Muhammad, Geirsson, Arnar, Desai, Nihar R., Ahmad, Tariq
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2021
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7924739/
https://ncbi.nlm.nih.gov/pubmed/33651802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0247789
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi